Monday, February 20, 2023

Gland Pharma to expand in Genome Valley with ₹400 crore investment

Generic-injectable focused firm will add capabilities at its existing facility to manufacture biologicals, biosimilar, antibodies, recombinant insulin

from | The Hindu https://ift.tt/gmVbMLW
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Sluggish pace of growth in revenue receipts in Telangana continue at the end of Q3

Tax revenue improves a little to cross 65% of the budget estimates during the period  from | The Hindu https://ift.tt/d8cFypm